Pancreatology

Papers
(The H4-Index of Pancreatology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Combination of novel biomarkers using liquid biopsy and imaging techniques as a more accurate tool for early detection of exocrine pancreatic cancer in high-risk populations206
Efficacy of endotherapy in the treatment of painful chronic pancreatitis : Predictors of response and impact on exocrine and endocrine insufficiency53
Radon exposure and risk of pancreatic cancer in an area with high levels of radon43
K-ras gene mutation analysis to diagnosis pancreatic adenocarcinoma from endoscopic ultrasound-guided tissue acquisition; a systematic review and meta-analysis41
Letter to the Editor regarding ‘Prevalence and risk factors of fatigue and its association with quality of life among patients with chronic pancreatitis: A cross-sectional study.’39
CFTR correction, as a new therapeutic option in the treatment of chronic pancreatitis37
Very early recurrecnce after R0∖∖R1 resection for pancreatic ductal adenocarcinoma: Proof of concept for a Уbiological R2Ф definition35
The mechanism of Neuropeptide Y mediated nerve-cancer crosstalk.33
Hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms.33
Impact of targeted SHP2-inhibition +/- MAPK-Inhibition on metabolic rewiring in pancreatic cancer32
Hereditary pancreatitis - report of 73 paediatric patients31
Biological role of acid sphingomyelinase for pancreatic carcinogenesis29
Fatty pancreas is a risk factor for pancreatic cancer: a systematic review and meta-analysis of 2956 patients29
Results of the first investigation about the understanding and engagement at time of diagnosis of patients with pancreatic cancer: the Communi.CARE study27
Contrast-enhanced harmonic endoscopic ultrasonography for predicting the efficacy of first-line gemcitabine and nab-paclitaxel chemotherapy in pancreatic cancer26
ERAP2 is a novel target involved in autophagy and activation of pancreatic stellate cells via UPR signaling pathway24
Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel23
Associations between ABO, FUT2 and chronic pancreatitis: A comprehensive meta-analysis of multiple cohorts and public biobanks23
Factors affecting prognosis after pancreatectomies for pancreatic cancer: a multivariate analysis22
The phase 1/2 trial of indomethacin in chronic pancreatitis (The PAIR trial): Protocol for a parallel multi-center randomized controlled trial22
Endosonography in the diagnosis and treatment of acute peripancreatic fluid collections22
Impact of spatio-temporal recurrence pattern on overall survival for invasive intraductal papillary mucinous neoplasia – A comparison with pancreatic ductal adenocarcinoma22
Determining the role of Serpin E1/PAI-1 in the development and progression of chronic pancreatitis22
Perineural invasion score system and clinical outcomes in resected pancreatic cancer patients22
0.51058983802795